Indium (111In) Capromab Pendetide

From Handwiki
Indium (111In) capromab pendetide
Monoclonal antibody
TypeWhole antibody
SourceMouse
TargetGlutamate carboxypeptidase II
Clinical data
Trade namesProstascint
ATC code
  • V09IB04 (WHO)
Identifiers
CAS Number
  • 151763-64-3 ☒N (capromab)
    148805-91-8 (pendetide)
ChemSpider
  • none
UNII
  • 03MZ53X1YS
ChEMBL
  • ChEMBL1201579 ☒N
 ☒N☑Y (what is this?)  (verify)

Indium (111In) capromab pendetide (trade name Prostascint) is used to image the extent of prostate cancer.[1] Capromab is a mouse monoclonal antibody which recognizes a protein found on both prostate cancer cells and normal prostate tissue. It is linked to pendetide, a derivative of DTPA.[2] Pendetide acts as a chelating agent for the radionuclide indium-111. Following an intravenous injection of Prostascint, imaging is performed using single-photon emission computed tomography (SPECT).[1]

Early trials with yttrium (90Y) capromab pendetide were also conducted.[3]

References

  1. 1.0 1.1 "Indium-111 capromab pendetide in the management of recurrent prostate cancer". Expert Review of Anticancer Therapy 8 (2): 175–81. February 2008. doi:10.1586/14737140.8.2.175. PMID 18279057. 
  2. WHO Drug Information
  3. "A phase II study of [90Y] yttrium-capromab pendetide in the treatment of men with prostate cancer recurrence following radical prostatectomy". Cancer Biotherapy & Radiopharmaceuticals 14 (2): 99–111. April 1999. doi:10.1089/cbr.1999.14.99. PMID 10850293. 




Retrieved from "https://handwiki.org/wiki/index.php?title=Chemistry:Indium_(111In)_capromab_pendetide&oldid=3422106"

Categories: [Radiopharmaceuticals] [Indium compounds]


Download as ZWI file | Last modified: 09/13/2024 23:28:00 | 12 views
☰ Source: https://handwiki.org/wiki/Chemistry:Indium_(111In)_capromab_pendetide | License: CC BY-SA 3.0

ZWI is not signed. [what is this?]